Aquestive Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AQST and other ETFs, options, and stocks.About AQST
Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz.
CEODaniel Barber
CEODaniel Barber
Employees142
Employees142
HeadquartersWarren, New Jersey
HeadquartersWarren, New Jersey
Founded2004
Founded2004
Employees142
Employees142
AQST Key Statistics
Market cap706.40M
Market cap706.40M
Price-Earnings ratio-8.26
Price-Earnings ratio-8.26
Dividend yield—
Dividend yield—
Average volume2.20M
Average volume2.20M
High today$5.93
High today$5.93
Low today$5.78
Low today$5.78
Open price$5.84
Open price$5.84
Volume4.55M
Volume4.55M
52 Week high$7.55
52 Week high$7.55
52 Week low$2.12
52 Week low$2.12
Stock Snapshot
The current Aquestive Therapeutics(AQST) stock price is $5.80, with a market capitalization of 706.4M. The stock trades at a price-to-earnings (P/E) ratio of -8.26.
As of 2025-12-19, Aquestive Therapeutics(AQST) stock has fluctuated between $5.78 and $5.93. The current price stands at $5.80, placing the stock +0.4% above today's low and -2.1% off the high.
Aquestive Therapeutics(AQST) shares are trading with a volume of 4.55M, against a daily average of 2.2M.
In the last year, Aquestive Therapeutics(AQST) shares hit a 52-week high of $7.55 and a 52-week low of $2.12.
In the last year, Aquestive Therapeutics(AQST) shares hit a 52-week high of $7.55 and a 52-week low of $2.12.
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own AQST. This list is generated using Robinhood data, and it’s not a recommendation.